This inventor holds 5 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Torii & Co., Ltd., Taiho Pharmaceutical Company Limited. Active years: 1988-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Otsu, JP (1988 - 1992)
- Ohtsu, JP (1996)
Company Filing History:


Years Active: 1988-1996
Title: The Innovative Contributions of Shinichi Watanabe
Introduction
Shinichi Watanabe is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 5 patents to his name, Watanabe's work has had a notable impact on medical science.
Latest Patents
Watanabe's latest patents include innovative compounds such as oxazolidine derivatives and pharmaceutically acceptable salts thereof. He has also developed phenylcarboxylic acid derivatives that possess hetero rings. These compounds are designed to inhibit fatty acid and cholesterol synthesis, making them useful as an antilipidemic agent and for the prophylactic and treatment of conditions such as arteriosclerosis, obesity, and diabetes.
Career Highlights
Throughout his career, Watanabe has worked with esteemed organizations, including Otsuka Pharmaceutical Company, Limited and Torii & Co., Ltd. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Watanabe has collaborated with notable colleagues, including Hiroyuki Kawamura and Setsurou Fujii. These partnerships have fostered a collaborative environment that has led to the advancement of innovative pharmaceutical solutions.
Conclusion
Shinichi Watanabe's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of important medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile